COMBINED IV IRON AND ULTRA LOW-DOSE ERYTHROPOIETIN (RHUEPO) THERAPY IN HEMODIALYSIS-PATIENTS

被引：0
|
作者：
TSOBANELIS, T
HOPPE, D
SCIGALLA, P
GRUTZMACHER, P
机构：
[1] ST MARKUS HOSP,MED CLIN 2,FRANKFURT,GERMANY
[2] BOEHRINGER MANNHEIM GMBH,W-6800 MANNHEIM 31,GERMANY
来源：
KIDNEY INTERNATIONAL | 1992年 / 41卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：496 / 496
页数：1
相关论文
共 50 条
  • [31] IS FOLATE SUPPLEMENTATION NECESSARY IN HEMODIALYSIS-PATIENTS ON ERYTHROPOIETIN THERAPY
    ONO, K
    HISASUE, Y
    CLINICAL NEPHROLOGY, 1992, 38 (05) : 290 - 292
  • [32] EFFICACY OF LOW-DOSE HUMAN ERYTHROPOIETIN IN CHRONIC-HEMODIALYSIS PATIENTS
    SOLOZABAL, C
    MADUELL, F
    FONSECA, F
    UNZUE, J
    ASIN, J
    KIDNEY INTERNATIONAL, 1991, 40 (02) : 355 - 355
  • [33] LOW TESTOSTERONE-(T) LEVELS INCREASE IN MALE HEMODIALYSIS-PATIENTS (HDP) TREATED WITH RECOMBINANT HUMAN ERYTHROPOIETIN (RHUEPO)
    HALEY, NR
    MATSUMOTO, AM
    ESCHBACH, JW
    ADAMSON, JW
    KIDNEY INTERNATIONAL, 1989, 35 (01) : 193 - 193
  • [34] HYPERTENSION FOLLOWING ERYTHROPOIETIN THERAPY IN ANEMIC HEMODIALYSIS-PATIENTS
    BUCKNER, FS
    ESCHBACH, JW
    HALEY, NR
    DAVIDSON, RC
    ADAMSON, JW
    AMERICAN JOURNAL OF HYPERTENSION, 1990, 3 (12) : 947 - 955
  • [35] THE BENEFICIAL EFFECT OF LOW INITIAL DOSE AND GRADUAL INCREASE OF ERYTHROPOIETIN TREATMENT IN HEMODIALYSIS-PATIENTS
    WALTER, J
    GAL, J
    TARABA, I
    ARTIFICIAL ORGANS, 1995, 19 (01) : 76 - 80
  • [36] HEMODYNAMIC AND VOLUME CHANGES BY RECOMBINANT-HUMAN-ERYTHROPOIETIN (RHUEPO) IN THE TREATMENT OF ANEMIC HEMODIALYSIS-PATIENTS
    HORI, K
    ONOYAMA, K
    ISEKI, K
    FUJIMI, S
    FUJISHIMA, M
    CLINICAL NEPHROLOGY, 1990, 33 (06) : 293 - 298
  • [37] OPTIMAL HEMATOCRIT FOR THE MAXIMUM OXYGEN-SUPPLY TO THE BRAIN WITH ERYTHROPOIETIN (RHUEPO) TREATMENT IN HEMODIALYSIS-PATIENTS
    HIRAKATA, H
    KANAI, H
    OKUDA, S
    FUJISHIMA, M
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1994, 5 (03): : 453 - 453
  • [38] WHY DO SOME HEMODIALYSIS-PATIENTS (HDP) NEED LARGE DOSES OF RECOMBINANT ERYTHROPOIETIN (RHUEPO)
    ADAMSON, JW
    EGRIE, JC
    HALEY, NR
    SCHNEIDER, GL
    SHERRARD, DJ
    ESCHBACH, JW
    KIDNEY INTERNATIONAL, 1990, 37 (01) : 235 - 235
  • [39] INTRAVENOUS ERYTHROPOIETIN (RHUEPO) ADMINISTRATION INCREASES PLASMA ENDOTHELIN AND BLOOD-PRESSURE IN HEMODIALYSIS-PATIENTS
    CARLINI, R
    OBIALO, CI
    ROTHSTEIN, M
    AMERICAN JOURNAL OF HYPERTENSION, 1993, 6 (02) : 103 - 107
  • [40] THROMBOLYSIS OF OCCLUDED CENTRAL VENOUS CATHETERS WITH LOW-DOSE UROKINASE IN HEMODIALYSIS-PATIENTS
    PRISCHL, FC
    WALLNER, M
    BERENT, R
    LENGLINGER, F
    KRAMAR, R
    NIEREN-UND HOCHDRUCKKRANKHEITEN, 1995, 24 (07) : 319 - 323
12345